The updated mRNA-1273.815 COVID-19 vaccine was significantly protective against hospitalization and medically attended outcomes among adults in the United States.
A new study from Memorial Sloan Kettering Cancer Center has shown that an RNA-based neoantigen vaccine can generate ...
A group of leading African researchers trying to develop effective vaccines against HIV is trying to figure out how to ...
Researchers who collaborate with US agencies have been asked to declare any links to China, communism and whether they comply ...
Sigyn Therapeutics, Inc. ("Sigyn" or the "Company") (OTCQB: SIGY) today released the following note authored by its CEO, Jim Joyce. Dear Reader, Blood purification technologies have emerged to become ...
Emergent BioSolutions Inc. (NYSE: EBS), a leading public health company that delivers protective and life-saving solutions ...
StockStory.org on MSN11h
3 Reasons MRNA is Risky and 1 Stock to Buy InsteadModerna has gotten torched over the last six months - since September 2024, its stock price has dropped 51.2% to $33.99 per ...
Nearly three years ago, on the eve of the election, I wrote my debut Spectator Australia article calling for a pandemic ...
Despite having one of the most sophisticated health care systems in the world, the U.S. response to the coronavirus pandemic fell well short when compared to other developed nations.
Under normal circumstances, the study of health problems after COVID vaccinations posted online on Feb. 25 might not have ...
Moderna CEO Stéphane Bancel received an annual compensation package worth $19.87 million last year, the largest he’s ever ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results